Cannara Biotech, Inc. (DELISTED) (LOVE.V:DL)
1.87
-0.02
(-1.06%)
CAD |
TSXV |
Mar 02, 15:45
Cannara Biotech EPS Diluted (Quarterly) : 0.0108 for Nov. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Medexus Pharmaceuticals, Inc. | 0.0034 |
| Theralase Technologies, Inc. | -0.004 |
| Cronos Group, Inc. | -0.0066 |
| Auxly Cannabis Group, Inc. | 0.0128 |
| Medicenna Therapeutics Corp. | -0.0523 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.040M |
| Revenue (Quarterly) | 30.11M |
| Total Expenses (Quarterly) | 29.07M |
| Enterprise Value | 199.31M |
| Gross Profit Margin (Quarterly) | 20.38% |
| Profit Margin (Quarterly) | 3.45% |
| Earnings Yield | 6.82% |
| Normalized Earnings Yield | -4.503 |